Last 47 quarters of trend data · Basic Materials · Chemicals - Specialty
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
EV/EBITDA has expanded 410.9% YoY to 45.8x, reflecting rising market expectations or slowing EBITDA growth.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -8.75 | — | — | 9.90 | — | — | — | — | 12.01 | 19.31 | — | 53.94 | — |
| — | — | — | — | — | — | — | — | — | +147.6% | — | +1230.5% | — | |
| P/S Ratio | 0.58 | 0.60 | 0.33 | 0.40 | 0.27 | 0.37 | 0.45 | 0.51 | 0.55 | 0.72 | 0.83 | 0.71 | 0.84 |
| — | +61.4% | -26.5% | -21.5% | -51.1% | -48.6% | -45.3% | -28.5% | -34.9% | -1.8% | -3.3% | +29.4% | +25.4% | |
| P/B Ratio | 13.44 | 15.35 | 7.07 | 7.93 | 7.20 | 3.51 | 4.19 | 4.62 | 4.67 | 5.23 | 6.34 | 5.57 | 6.79 |
| — | +337.6% | +69.0% | +71.9% | +54.0% | -32.9% | -34.0% | -17.1% | -31.2% | +41.8% | +52.8% | +83.8% | +61.4% | |
| P/FCF | 65.93 | — | 4.82 | 5.67 | 8.60 | — | 21.83 | 12.07 | — | — | 3.38 | 22.90 | 152.78 |
| — | — | -77.9% | -53.1% | — | — | +546.5% | -47.3% | — | — | -72.7% | +439.0% | +2637.3% | |
| EV / EBITDA | 21.72 | 45.80 | — | 8.45 | 9.25 | 8.96 | 10.09 | 8.42 | 8.60 | 10.13 | 10.75 | 10.20 | 7.91 |
| — | +410.9% | — | +0.3% | +7.5% | -11.5% | -6.1% | -17.5% | +8.7% | +58.8% | -59.2% | +107.2% | +18.9% | |
| EV / EBIT | — | 45.80 | — | 12.99 | 19.53 | 22.55 | 20.31 | 43.18 | 13.50 | 14.01 | 20.27 | 17.25 | 11.08 |
| — | +103.1% | — | -69.9% | +44.7% | +60.9% | +0.2% | +150.3% | +21.9% | +61.2% | — | +261.0% | +25.4% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
The Chemours Company's operating margin was 2.8% in Q1 2026, up 22.3 pp QoQ and down 2.9 pp YoY. The trailing four-quarter average of -1.3% lags the current quarter, suggesting the recent improvement is above-trend. Gross margin contracted 11.0% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 15.5% | 15.4% | 11.5% | 15.7% | 17.2% | 17.3% | 19.6% | 19.1% | 19.8% | 20.9% | 18.1% | 18.4% | 25.0% |
| — | -11.0% | -41.3% | -17.5% | -13.1% | -17.3% | +8.4% | +3.8% | -20.6% | -13.0% | +19.6% | -24.5% | -3.8% | |
| Operating Margin | -0.1% | 2.8% | -19.5% | 7.0% | 4.5% | 5.7% | 5.4% | 8.1% | 8.4% | 8.3% | 7.6% | 7.4% | 11.9% |
| — | -50.5% | -462.0% | -14.4% | -46.7% | -31.3% | -29.0% | +9.9% | -29.5% | -41.5% | +2634.4% | -49.2% | +3.3% | |
| Net Margin | -6.6% | -2.1% | -4.6% | 4.0% | -23.6% | -0.3% | -0.6% | -1.8% | 3.9% | 4.0% | -1.3% | 0.8% | -22.9% |
| — | -618.2% | -699.2% | +323.1% | -711.0% | -107.4% | +55.0% | -322.9% | +116.9% | -58.0% | +82.4% | -94.0% | -318.0% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -90.2% | -12.4% | -22.1% | 22.3% | -93.0% | -0.7% | -1.3% | -3.9% | 8.1% | 7.2% | -2.4% | 1.5% | -36.9% |
| — | -1739.7% | -1649.2% | +670.6% | -1246.7% | -109.3% | +47.4% | -354.7% | +122.0% | -41.8% | +70.3% | -92.0% | -318.6% | |
| ROA | -5.2% | -0.4% | -0.8% | 0.8% | -5.1% | -0.1% | -0.1% | -0.4% | 0.8% | 0.7% | -0.2% | 0.2% | -4.9% |
| — | -637.2% | -664.0% | +317.1% | -749.7% | -108.1% | +51.9% | -338.6% | +116.0% | -65.0% | +82.4% | -95.0% | -286.7% | |
| ROIC | -0.1% | 0.7% | -4.7% | 1.9% | 1.2% | 1.3% | 1.3% | 2.1% | 2.3% | 2.1% | 2.0% | 2.0% | 3.6% |
| — | -46.8% | -459.2% | -10.0% | -44.7% | -36.0% | -35.1% | +2.9% | -36.4% | -47.8% | +2708.9% | -59.2% | -15.4% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
The Chemours Company's Debt/EBITDA ratio is 112.6x — elevated, raising questions about debt serviceability. Debt/Equity has risen for 3 consecutive quarters, indicating increasing financial leverage that investors should watch closely.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 18.27 | 20.33 | 18.27 | 14.72 | 18.44 | 7.55 | 7.20 | 6.51 | 5.84 | 5.65 | 5.82 | 5.59 | 4.79 |
| — | +169.1% | +153.8% | +126.1% | +215.6% | +33.7% | +23.7% | +16.5% | +22.0% | +79.3% | +66.0% | +90.2% | +48.8% | |
| Debt / EBITDA | 13.69 | 112.59 | — | 24.13 | 28.99 | 26.39 | 28.46 | 21.45 | 20.76 | 23.15 | 23.75 | 22.74 | 14.21 |
| — | +326.6% | — | +12.5% | +39.6% | +14.0% | +19.8% | -5.7% | +46.2% | +77.7% | -57.1% | +98.8% | +6.1% | |
| Current Ratio | 1.78 | 1.82 | 1.78 | 1.71 | 1.68 | 1.75 | 1.68 | 1.73 | 1.89 | 1.61 | 1.54 | 1.68 | 1.54 |
| — | +3.8% | +6.1% | -1.6% | -11.2% | +8.7% | +8.8% | +3.3% | +22.4% | -12.1% | -9.2% | -7.6% | -19.4% | |
| Quick Ratio | 0.85 | 0.87 | 0.85 | 0.88 | 0.83 | 0.83 | 0.86 | 0.92 | 1.01 | 0.99 | 1.00 | 1.08 | 0.88 |
| — | +4.7% | -1.5% | -4.4% | -17.3% | -16.4% | -13.7% | -14.4% | +14.5% | +0.6% | +4.3% | -5.2% | -30.4% | |
| Interest Coverage | -0.03 | 0.57 | -1.10 | 1.75 | 1.09 | 1.00 | 1.13 | 0.57 | 1.97 | 2.11 | 1.52 | 2.00 | 4.06 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare business quality, growth, and profitability against top sector peers.
Start ComparisonQuick answers to the most common questions about buying CC stock.
The Chemours Company's current P/E is -8.8x. The average P/E over the last 1 quarters is 9.9x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
The Chemours Company's current operating margin is -0.1%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking The Chemours Company's business trajectory between earnings reports.